Vittorio Bini
Papers
4
Total Citations
275
H-Index
4
About
Vittorio Bini is a leading urological researcher whose work centers on improving the detection and management of prostate cancer and pelvic floor disorders. His most significant contributions involve the clinical application of the prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and the Prostate Health Index (PHI). Bini’s landmark 2011 study, cited over 120 times, demonstrated that these biomarkers could predict pathologic outcomes—such as aggressive disease—in men undergoing radical prostatectomy, offering a more precise tool than traditional PSA testing alone. He further validated these findings in a multicentric European prospective study, solidifying their clinical utility. Notably, Bini also investigated p2PSA’s ability to detect biochemical recurrence of prostate cancer earlier than standard PSA, addressing a critical need for timely intervention post-surgery. Beyond oncology, Bini has advanced surgical techniques in urogynecology, leading a prospective randomized trial comparing robot-assisted to laparoscopic sacrocolpopexy for high-stage pelvic organ prolapse. With over 275 combined citations across his key papers, Bini’s research bridges biomarker innovation and surgical outcomes, making him a pivotal figure in precision urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4